Comments on "Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor(CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lympho"
-
-
关键词:
- 白血病,淋巴细胞,急性 /
- CAG预激方案 /
- CVAD方案
-
Key words:
- acute lymphoblastic leukemia /
- CAG regimen /
- CVAD regimen
-
-
[1] Inaba H,Greaves M,Mullighan CG.Acute lymphoblastic leukaemia[J].Lancet,2013,381:1943-1955.
[2] Pui CH,Evans WE.Treatment of acute lymphoblastic leukemia[J].N Engl J Med,2006,354:166-178.
[3] Huguet F,Leguay T,Raffoux E,et al.Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia:the GRAALL-2003 study[J].J Clin Oncol,2009,27:911-918.
[4] Al-Khabori M,Minden MD,Yee KW,et al.Improved survival using an intensive,pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia[J].Leuk Lymphoma,2010,51:61-65.
[5] Ko RH,Ji L,Barnette P,et al.Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia:a Therapeutic Advances in Childhood Leukemia Consortium study[J].J Clin Oncol,2010,28:648-654.
[6] Oriol A,Vives S,Hernández-Rivas JM,et al.Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group[J].Haematologica,2010,95:589-596.
[7] Tavernier E,Boiron JM,Huguet F,et al.Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial[J].Leukemia,2007,21:1907-1914.
[8] Fielding AK,Richards SM,Chopra R,et al.Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL);an MRC UKALL12/ECOG 2993 study[J].Blood,2007,109:944-950.
[9] Kozlowski P,Aström M,Ahlberg L,et al.High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007[J].Haematologica,2012,97:1414-1421.
[10] Liu L,Jiao W,Zhang Y,et al.Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia[J].Leuk Res,2015,39:323-328.
[11] Vellenga E,Young DC,Wagner K,et al.The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia[J].Blood,1987,69:1771-1776.
[12] Schiffer CA.Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia[J].Blood,1996,88:3675-3685.
[13] Yamada K,Furusawa S,Saito K,et al.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study[J].Leukemia,1995,9:10-14.
[14] Saito K,Furusawa S,Yamada K,et al.Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia[J].Rinsho Ketsueki,1995,36:165-174.
[15] 吴德沛,吴小津,石培民,等.含G-CSF的预激方案用于难治性或复发性急性髓系白血病治疗的临床研究[J].中华血液学杂志,2004,25(1):51-52.
[16] Li JM,Shen Y,Wu DP,et al.Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome:a multicenter study of 112 Chinese patients[J].Int J Hematol,2005,82:48-54.
[17] Bai A,Kojima H,Hori M,et al.Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells[J].Exp Hematol,1999,27:259-265.
[18] 钟济华,陈芳源,王海嵘,等.CAG方案对急性髓系白血病细胞作用机制的研究[J].中华血液学杂志,2006,27(7):492-494.
[19] Avalos BR.Molecular analysis of the granulocyte colony-stimulating factor receptor[J].Blood,1996,88:761-777.
[20] Yang X,Liu F,Xu Z,et al.Expression of granulocyte colony stimulating factor receptor in human colorectal cancer[J].Postgrad Med J,2005,81:333-337.
[21] Solaroglu I,Cahill J,Jadhav V,et al.A novel neuroprotectant granulocyte-colony stimulating factor[J].Stroke,2006,37:1123-1128.
[22] Sloand EM,Kim S,Maciejewski JP,et al.Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo[J].Blood,2000,95:2269-2274.
[23] Franzke A,Piao W,Lauber J,et al.G-CSF as immune regulator in T cells expressing the G-CSF receptor:implications for transplantation and autoimmune diseases[J].Blood,2003,102:734-739.
[24] Matsushita K,Arima N.Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells[J].Leuk Lymphoma,1998,31:295-304.
[25] Morikawa K,Morikawa S,Miyawaki T,et al.Constitutive expression of granulocyte-colony stimulating factor receptor on a human B-lymphoblastoid cell line[J].Br J Haematol,1996,94:250-257.
[26] Tsuchiya H,El-Sonbaty SS,Watanabe M,et al.Analysis of myeloid characteristics in acute lymphoblastic leukemia[J].Leuk Res,1993,17:809-813.
[27] 薛胜利,吴德沛,孙爱宁,等.CAG方案治疗复发或初次诱导缓解治疗失败的T细胞急性淋巴细胞白血病[J].白血病.淋巴瘤,2007,16(2):120-122.
[28] 计成阜,孙爱宁,吴德沛,等.CAG方案治疗七例成人难治、复发性急性淋巴细胞白血病疗效观察[J].中华血液学杂志,2007,28(1):47-48.
[29] Xue SL,Wu DP,Sun AN,et al.CAG regimen enables relapsed or refractory T-cell acute lymphocytic leukemia patients to achieve complete remission:a report of six cases[J].Am J Hematol,2008,83:167-170.
[30] Xue SL,Cui HX,Zou JY,et al.Low-dose cytarabine and aclarubicin combinedwith granulocyte colony-stimulating factor for the treatment of relapsed orprimary refractory acute lymphocytic leukemia:a retrospective study of 25 Chinese patients[J].Hematol Oncol,2013,31:206-212.
[31] 薛胜利,戴兰,乔曼,等.正常人外周血有核细胞膜表面G-CSFR受体的定量测定[J].中国免疫学杂志,2011,27(1):54-59.
[32] 薛胜利.预激方案对难治、复发ALL治疗的临床及机制研究[D].苏州:苏州大学,2011.
[33] 吴艳玲,薛胜利,孙爱宁,等.CAG方案清除T细胞急性淋巴细胞白血病细胞株A3细胞作用机制的研究[J].中国实验血液学杂志,2008,16(6):1279-1282.
[34] 薛胜利,戴兰,陈艳,等.G-CSF对急性淋巴细胞白血病细胞株增殖活性的影响及协同化疗药物杀伤作用的研究[J].中华血液学杂志,2011,32(1):61-63.
[35] Jilma B,Hergovich N,Homoncik M,et al.Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans[J].Br J Haematol,2000,111:314-320.
[36] Berliner N.Lessons from congenital neutropenia:50 years of progress in understanding myelopoiesis[J].Blood,2008,111:5427-5432.
-
计量
- 文章访问数: 137
- PDF下载数: 113
- 施引文献: 0
下载: